comprehensive -WSS

comprehensive

author：explore 2025-09-27 16:46:10 - browse：3755

Medicare and money photo illustration. — Adobe

WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment, insurers are finalizing their plans to cover it as well as associated scans and diagnostic tests.

Medicare will cover most patients eligible for Leqembi, a new treatment developed by Eisai and Biogen to help slow the progression of Alzheimer’s disease. The drug, which has modest benefits, has potentially serious side effects for some patients including brain swelling and bleeding.

Medicare told STAT that it would cover brain scans and genetic testing that will help screen for and monitor potential side effects. Medicare already covers one amyloid PET scan per lifetime, but the agency is reconsidering that policy and plans to release a new proposed policy “soon,” an agency spokesperson said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： H.R. 3 is the wrong path to lower drug costs

focus

WSS

6 surprising facts about sugar

Texas board proposes rules on abortion law emergency exemption

Study links childhood stress with decline in older age

Asbestos ban is immediate, but health effects will linger for decades

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

It costs an awful lot of money to give away a kidney

focus

comprehensive

knowledge

How to save PrEP access — and even expand it

Erich Jarvis studies song birds to learn about human stuttering

Apple is now the first public company to be valued at $3 trillion

The cancer stories no one wants to hear

Tori Bowie and the unacceptable rates of Black maternal death

Cancer, immunology, HIV research ensnared in fetal tissue politics

Medicare details structure of new drug price negotiation program

Chinese researcher claims birth of first gene

Heart attack and stroke risk calculators need revising

The a glaring gap in research on serious mental illness and primary care

focus

Steward Health Care expansion into Malta flopped

Readout Newsletter: Illumina, CRISPR, Regeneron

6 surprising facts about sugar

U.K. officials, researchers try to ease path for bespoke genetic treatments

Bring on the sabbaticals for nurses

Bring on the sabbaticals for nurses

focus

focus

explore

Wikipedia